Cargando…

The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia

Negative symptoms are core features of schizophrenia-spectrum disorders that are frequently observed across all phases of illness. By their nature, COVID-19 social isolation, physical distancing, and health precautions induce behavioural aspects of negative symptoms. However, it is unclear whether t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strauss, Gregory P., Macdonald, Kelsey I., Ruiz, Ivan, Raugh, Ian M., Bartolomeo, Lisa A., James, Sydney H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057945/ https://www.ncbi.nlm.nih.gov/pubmed/33881621 http://dx.doi.org/10.1007/s00406-021-01260-0

Ejemplares similares

The effects of the COVID-19 pandemic on hallucinations and delusions in youth at clinical high-risk for psychosis and outpatients with schizophrenia
por: Berglund, Alysia M., et al.
Publicado: (2023)

Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis
por: Macdonald, Kelsey I., et al.
Publicado: (2022)

Beliefs About the Uncontrollability and Usefulness of Emotion in the Schizophrenia-Spectrum: Links to Emotion Regulation and Negative Symptoms
por: Berglund, Alysia M., et al.
Publicado: (2023)

Emotion regulation and social knowledge in youth at clinical high‐risk for psychosis and outpatients with chronic schizophrenia: Associations with functional outcome and negative symptoms
por: Macfie, William G., et al.
Publicado: (2022)

The positivity offset theory of anhedonia in schizophrenia: evidence for a deficit in daily life using digital phenotyping
por: Bartolomeo, Lisa A., et al.
Publicado: (2023)

Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia
por: Strauss, Gregory P., et al.
Publicado: (2022)

Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
por: Strauss, Gregory P., et al.
Publicado: (2021)

Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status
por: Tran, Tanya, et al.
Publicado: (2023)

A Bioecosystem Theory of Negative Symptoms in Schizophrenia
por: Strauss, Gregory P.
Publicado: (2021)

Trait emotional experience in individuals with schizophrenia and youth at clinical high risk for psychosis
por: Yee, Claire I., et al.
Publicado: (2019)

Persistent negative symptoms in individuals at Ultra High Risk for psychosis
por: Yung, Alison R., et al.
Publicado: (2019)

S79. REINFORCEMENT LEARNING ABNORMALITIES IN INDIVIDUALS AT CLINICAL HIGH RISK AND IN THE FIRST EPISODE OF PSYCHOSIS
por: Datta, Raktima, et al.
Publicado: (2020)

M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Chi Yiu Wong, Sandra, et al.
Publicado: (2020)

Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis
por: Hermans, Karlijn S. F. M., et al.
Publicado: (2021)

A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia
por: Vakalopoulos, Costa
Publicado: (2010)

Negative symptoms in first episode schizophrenia: Results from the “parma early psychosis” program
por: Pelizza, L., et al.
Publicado: (2021)

Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis
por: Hauke, Daniel J., et al.
Publicado: (2021)

Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
por: Davidson, Michael, et al.
Publicado: (2022)

NEGATIVE SYMPTOMS AND NEGATIVE SCHIZOPHRENIA
por: Chaturvedi, S.K., et al.
Publicado: (1984)

Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2014)

Negative symptoms in schizophrenia
por: Mitra, Sayantanava, et al.
Publicado: (2016)

Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of DAO, DAOA, and NRG1 Variants with Negative Symptoms and Cognitive Deficits
por: Jagannath, Vinita, et al.
Publicado: (2017)

The COVID-19 Pandemic Introduces Diagnostic and Treatment Planning Complexity for Individuals at Clinical High Risk for Psychosis
por: Mittal, Vijay A, et al.
Publicado: (2021)

NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND DEPRESSION
por: Chaturvedi, S.K., et al.
Publicado: (1985)

Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms
por: Lee, So Jung, et al.
Publicado: (2017)

Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms
por: Lee, So Jung, et al.
Publicado: (2017)

Neural correlates of positive and negative symptoms through the illness course: an fMRI study in early psychosis and chronic schizophrenia
por: Vanes, Lucy D., et al.
Publicado: (2019)

A Network Approach to Trauma, Dissociative Symptoms, and Psychosis Symptoms in Schizophrenia Spectrum Disorders
por: Schlesselmann, Ante J, et al.
Publicado: (2022)

Structure of Negative Symptoms in Schizophrenia: An Unresolved Issue
por: Russo, Manuela, et al.
Publicado: (2021)

Identifying persistent negative symptoms in first episode psychosis
por: Hovington, Cindy L, et al.
Publicado: (2012)

O6.6. MULTIMODAL PROGNOSIS OF NEGATIVE SYMPTOM SEVERITY IN INDIVIDUALS WITH INCREASED RISK OF DEVELOPING PSYCHOSIS
por: Hauke, Daniel, et al.
Publicado: (2020)

Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls
por: Shafee, Rebecca, et al.
Publicado: (2018)

2329 Associations between inflammatory markers and negative symptoms in individuals with schizophrenia: Converging evidence
por: Goldsmith, David, et al.
Publicado: (2018)

Symptoms and Etiological Attribution: A Cross-Sectional Study in Mexican Outpatients with Psychosis and Their Relatives
por: Gómez-de-Regil, Lizzette, et al.
Publicado: (2016)

Tackling Negative Symptoms of Schizophrenia with Memantine
por: Paraschakis, Antonios
Publicado: (2014)

The Effects of Bupropion on Negative Symptoms in Schizophrenia
por: Yassini, Mojtaba, et al.
Publicado: (2014)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Treating Negative Symptoms in Schizophrenia: an Update
por: Remington, Gary, et al.
Publicado: (2016)

Primary and Secondary Negative Symptoms in Schizophrenia
por: Mosolov, Sergey N., et al.
Publicado: (2022)

MDMA for the Treatment of Negative Symptoms in Schizophrenia
por: Arnovitz, Mitchell D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qd3e1rajo9uev5hnl9p5r6f0ep